FPRX
Five Prime Therapeutics, Inc.
FPRX
FPRX
Delisted
FPRX was delisted on the 15th of April, 2021.
126 hedge funds and large institutions have $1B invested in Five Prime Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 42 reducing their positions, and 12 closing their positions.
Holders
126
Holders Change
+3
Holders Change %
+2.44%
% of All Funds
3.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
37
Reduced
42
Closed
12
Calls
$6.62M
Puts
$7.52M
Net Calls
-$898K
Net Calls Change
+$130K
Top Buyers
| 1 |
HM
1
HealthCor Management
New York
|
$41.4M |
| 2 |
PAMU
2
Pictet Asset Management (UK)
London,
United Kingdom
|
$19.2M |
| 3 |
3
Millennium Management
New York
|
$14.4M |
| 4 |
4
Axa
Paris,
France
|
$5.44M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$71.3M |
Top Sellers
| 1 |
1
Renaissance Technologies
New York
|
$2.89M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$41.3M |
| 3 |
MWNA
3
Marshall Wace North America
New York
|
$2.77M |
| 4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$4.61M |
| 5 |
5
Goldman Sachs
New York
|
$2.56M |
